Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Jul 11.
Published in final edited form as: ACS Comb Sci. 2011 Apr 28;13(4):357–364. doi: 10.1021/co200020j

Application of a Sparse Matrix Design Strategy to the Synthesis of DOS Libraries

Lakshmi B Akella 1, Lisa A Marcaurelle 1,*,
PMCID: PMC3133884  NIHMSID: NIHMS292766  PMID: 21526822

Abstract

We have implemented an interactive and practical sparse matrix design strategy for the synthesis of DOS libraries, which facilitates the selection of diverse library members within a user-defined range of physicochemical properties while still maintaining synthetic efficiency. The utility of this approach is illustrated with the synthesis of an 8,000-membered library of stereochemically diverse medium sized rings accessible via a build/couple/pair DOS strategy. Diverse library members were selected from a virtual library by applying the maximum dissimilarity method, while the selection of similar analogs around each diverse product was ensured by picking near neighbors algorithmically based on fingerprint comparison. Adjustable filters on compound properties, which can be tailored to suit the needs of the target biology, facilitated subset selection from the synthetically accessible compounds.

Keywords: library design, diversity-oriented synthesis, physicochemical properties, diversity-ranking, maximum dissimilarity, sparse matrix

Introduction

Designing libraries with properties suitable for use in biological screens and downstream discovery is a critical step in the synthesis of any compound collection.1 It has been noted that compounds resulting from diversity-oriented synthesis (DOS) often violate Lipinski’s Rule of 52 with high molecular weight and predicted low solubility.1,3 The outcome of any library synthesis, however, is a product of the design. A primary goal of DOS is the synthesis of skeletally diverse small molecules of increased structural complexity (e.g., high sp3 content, multiple stereogenic centers) that can be accessed in relatively few synthetic steps.4 If effort is taken up front to control the physicochemical properties of DOS library members, these structural features can be achieved while still producing compounds with favorable physicochemical properties.

When designing a small-molecule library for high-throughput screening, chemists are faced with the challenge of selecting which compounds to synthesize. There exists abundant literature on various computational library design methods to choose an optimal subset for synthesis (or screening) from large chemical spaces.5 The two main approaches are reagent- and product-based design.6,7 We have combined both of these design strategies for the synthesis of DOS libraries, which we illustrate here with an 8,000-membered library of stereochemically diverse medium-sized rings. The DOS scaffold that was selected as a starting point for library design is shown in Figure 1, along with a set of structurally related scaffolds.8 The latter will be used to compare differences in design strategies as they influence the physicochemical property profile of library members (vide infra). The process employed for the selection of the scaffold itself involved the use of various methods commonly employed for assessing diversity (e.g., Principal Moments of Inertia, Multi-fusion Similarity, Principal Component Analysis).9 The synthesis of the SNAr-Pyr scaffold and its corresponding stereoisomers is the subject of a separate communication.10

Figure 1.

Figure 1

SNAr-based DOS library scaffolds (R1 = Diversity site 1, R2 = Diversity site 2)

Three approaches have been utilized for the design of compound libraries: (1) a full matrix design where every reagent at R1 is combined with every reagent at R2 thus forming the maximum number of products, (2) a sparse matrix design strategy5b,11 where a subset of products are selected for synthesis and not all reagent combinations are selected and (3) a cherry pick strategy5c where a subset of products (diverse or similar) is selected for synthesis. Although we have utilized a full matrix approach for previous DOS efforts8 a sparse matrix design strategy appealed to us for the purpose of controlling the physicochemical properties of the library members as well as maximizing coverage of chemical space. While diverse chemical space with suitable physicochemical properties can be achieved through a cherry pick approach (using a combination of property-based filtering and diversity-ranking) we generally reserve this method for small compound libraries (<100 compounds). We envisioned that a sparse matrix approach would allow for the selection of ‘near neighbors’ around each diverse molecule thus facilitating access to built-in structural analogs in contrast to a diversity-ranking approach. In this regard a sparse matrix design achieves a balance between a full matrix design and cherry picking.

The design process we have implemented involves the following: 1) creation of master lists for the various reagent classes, 2) library enumeration based on defined production pathways 3) and compound selection using the sparse matrix approach. The design is carried out on a single stereoisomer and applied to all the other stereoisomers12 thereby maintaining the ability to generate stereo/structure-activity relationships upon biological testing. 8 Details of the design workflow are outlined below.13

Results and Discussion

Master Reagent Lists

Before a virtual library could be created for product-based selection, a list of suitable building blocks for each reagent class was required. As selecting reagents intuitively from large databases is an arduous task, several software tools and systems have been developed to aid in the filtering process.11,14 At our end we have implemented a reagent selection process that takes into consideration diversity (with respect to structure and properties), synthetic feasibility, availability and price. As shown in Figure 2 reagents for various reagent classes were retrieved from Available Chemicals Directory (ACD) by using functional group queries. Reagent classes included in our search were sulfonyl chlorides, isocyanates, aldehydes, acids, acid chlorides, alkynes, boronic acids and amines. The resulting reagents were filtered by molecular weight (≤ 200) and number of rotatable bonds (≤ 5) and then exported as structure definition files (sd files). The first step of the filtering process involved the stripping of salts and removal of duplicate molecules. General exclusion filters that were applicable to all reagent classes were created in the form of Daylight SMARTS queries. These filters include isotopes, inorganic elements, excessive number of halogens, charged species, peroxides, thiols, Michael acceptors, etc.15

Figure 2.

Figure 2

Workflow for the creation of master lists for various reagent classes

Reagent class specific filters were then applied to the reagent lists. For example, carboxylic acid specific exclusion filters included primary or secondary amines, formyl, nitro, nitroso, carboxyl count >2, isocyanate, imino, allene, epoxide, anhydride, etc. The successive filtering/eliminations resulted in a manageable and significantly reduced list for each reagent classes of interest. Various structural and physicochemical properties such as molecular weight, ALogP, polar surface area, number of acceptors, number of donors, number of rotatable bonds, number of rings, number of ring assemblies and ring size were calculated. Principal component analysis (PCA) was performed on the properties,16,17 followed by clustering on principal components using the maximum dissimilarity method18 for selecting cluster centers. The number of clusters is predefined (Table 1) depending on the reagent class size.

Table 1.

Reagent list generation

Reagent class Total Filtered # Clusters # Selected # SNAr-Pyra
Sulfonyl chlorides 171 153 30 23 11
Isocyanates 517 438 80 20 15
Aldehydes 5953 4307 120 46 22
Acids 17935 8551 200 26 24
Acid Chlorides 1008 780 60 30 N/A
Alkynes 1752 1270 120 23 23
Boronic Acids 1539 846 60 23 20
Amines 39453 21504 200 60 N/A
a

Not all reagents on the master list were used for library enumeration. (See Supporting Information).

Each reagent class was created as a project in Instant JChem and cluster centers were automatically marked to facilitate reagent selection. Chemists visually inspected the clusters and selected reagents manually (not always the cluster center) mindful of reactivity, synthetic feasibility, price and availability.19,20 Many clusters resulted in no selections due to lack of availability or medicinal chemistry considerations. When a particular structure was selected from a given cluster a small number of closely related analogs were also chosen from the same cluster to ensure SAR. Final selections consisted of 20–50 reagents per class. We periodically update the master reagent lists based on the synthetic outcomes or commercial availability. Our most current master reagent lists are provided in the Supporting Information.

The fragment property space for the master list of selected reagents can be visualized using a PCA plot (Figure 3A). Reagents that are close to each other on the plot are similar. The loadings plot (Figure 3B) shows the relationship between properties, which dictate the location of the fragment on the PCA plot. For example, properties that are negatively correlated such as TPSA and ALogP (which influence polarity and hydrophobicity respectively) appear on opposite sides of the plot. When in need of backup reagents (due to synthetic feasibility or unavailability), the selection of close analogs is facilitated by revisiting the clustered reagent lists and PCA plot. We anticipate these larger yet selected spaces to be useful upon screening when hits are identified and additional SAR expansion is required.

Figure 3.

Figure 3

(a) Principal component analysis (PCA) for reagent master lists based on fragments properties. (b) Loading plot displaying properties used in the analysis. Representative reagents are provided (A–E) to illustrate which properties influence their location on the PCA plot. (TPSA = topological polar surface area, HBD = number of hydrogen bond donors, HBA = number of hydrogen bond acceptors, Aromatic rings = number of aromatic rings, Rings = number of rings, Ring assembly = connectivity of rings).

Library Enumeration and Product Filtering

With the master lists of reagents in hand, a virtual library was constructed for the SNAr-Pyr scaffold where every reagent at R1 was used in all combinations with reagents at R2 thereby resulting in a full combinatorial matrix. All synthetically accessible production pathways were enumerated (including ‘skips’ at R1 or R2). The synthetic sequence for the SNAr-Pyr library is shown in Scheme 1. The reagent classes used at R1 included sulfonyl chlorides, isocyanates, acids and aldehydes while reagents used at R2 included boronic acids and alkynes for Suzuki and Sonogashira reactions respectively. Enumeration was reaction based; a full list of SMIRKS used for enumerating the SNAr-Pyr library are provided as Supporting Information. The total number of enumerated products for the SNAr-Pyr library is 3212 compounds (72 reagents (+ 1 skip) at R1 × 43 (+ 1 skip) reagents at R2). (Reagents at R1 containing aryl chlorides were removed due to incompatibility with the cross coupling step.) The in silico library enumeration and product filtering process is depicted in the Figure 4.

Scheme 1.

Scheme 1

Solid-phase synthesis plan for SNAr-Pyr library

Figure 4.

Figure 4

Workflow for in silico library enumeration and product filtering process

Next, molecular properties that affect solubility, permeability and bioavailability were calculated for each product.1,21 The properties and the threshold limits applied on the products are molecular weight (≤625), AlogP (−1 to 5), number of H-bond acceptors plus donors (≤10), number of rotatable bonds (≤10) and topological polar surface area (≤140). Structures that violated any single property were eliminated. We implemented a ‘75/25’ rule where the dataset was partitioned into two data streams based on molecular weight: less than 500 and greater than 500. This rule was applied to favor products with molecular weight less than 500, while still allowing for a small percentage of ‘Lipinski violators’ to be formed. The 75/25 rule is applied after reviewing the enumerated chemical space. If the enumerated chemical space largely occupies molecular weight <500 then the 75/25 rule is not applied. In the case of the SNAr-Pyr library the space is roughly equally distributed with respect to molecular weight partitioning.

Sparse matrix design

After filtering based on properties, a subset of products is chosen from the virtual library based on chemical similarity principles.22 The chemical similarity principle assumes that structurally similar compounds should have similar biological activity.23 Diverse molecules were selected from each partitioned data set based on the maximum dissimilarity method.14 The number of diverse molecules is user defined and is dependent on the library size. In this instance a 1000-membered library was desired. For every diverse molecule at most four near neighbors were selected algorithmically based on pairwise fingerprint similarity of the structures with a similarity threshold (Tanimoto coefficient, Tc) of 0.8 (Figure 6).24,25 A molecule already considered as a neighbor is dropped from future selection. The number of reagents selected for the SNAr-Pyr library production includes 24 acids, 22 aldehydes, 15 isocyanates and 11 sulfonyl chlorides, 20 boronic acids and 23 alkynes.26 For this particular library, relatively few reagents were dropped given the proportion of selected to enumerated space (1:3). For smaller libraries (or those with more than two diversity sites) a larger number of reagents tend to be dropped.

Figure 6.

Figure 6

Representative diverse seed for SNAr Pyr library and selected four near neighbors (Tc = Tanimoto coefficient).

To achieve synthetic efficiency during library production we typically set a minimum threshold for the number of products formed per reagent. This is done to prohibit the selection of reagents that form only a small number of products. The threshold is user defined and can vary by enumerated library size. For the SNAr-Pyr library, a minimum count of 5 products per reagent was applied. On review of the outcome of the design, excessive use of any one reagent is curtailed by applying a limiting filter and the design is repeated accordingly. If a problematic reagent is identified during feasibility studies that reagent can be dropped along with the associated products. In such situations new products are selected from the remaining chemical space that are dissimilar to already selected products.

Property Analysis

Following the implementation of the sparse matrix design we analyzed the selected product space with respect to molecular weight and ALogP. As shown in Figure 7 compounds selected for synthesis are uniformly distributed across the virtual chemical space with a greater number of compounds occupying the region MW <500. Also shown in the plot are compounds that passed the property criteria but were not selected and compounds that failed any single property filter (MW, ALogP, TPSA, rotatable bonds, etc).

Figure 7.

Figure 7

Scatter plot of molecular weight vs ALogP for the SNAr-Pyr library, selected (1000), not selected (2040) and failed (172).

Lastly we compared the property distribution of compounds resulting from a sparse vs full matrix design strategy in the context of a set of structurally related DOS scaffolds (structures shown in Figure 1). Similar to the SNAr-Pyr library a sparse matrix design strategy was applied to the SNAr-SO2 scaffold. Meanwhile a full matrix strategy was employed for the SNAr-8 and SNAr-9 scaffolds. (In the latter case, no property filters were applied.) The combined property analysis is shown in Figure 8. A mere visual inspection shows a clear shift in distribution in the desired direction for all properties, especially molecular weight and polar surface area. Mean values calculated for each of the descriptors at the library level also reflect the same (see Table 2). Noteably, for this particular set of scaffolds the mean ALogP, HBD and HBA values were deemed acceptable even without the sparse matrix design.

Figure 8.

Figure 8

Property distribution for SNAr-based DOS libraries: Full (blue) vs sparse (red) matrix design

Table 2.

Property analysis for SNAr-based DOS libraries: Full vs sparse matrix design

Property Full Matrix
(n = 13270)
Sparse Matrix
(n = 13735)
MW 576 494
ALogP 2.8 2.8
TPSA 129 100
Rotatable Bonds 8.5 7.2
HBA 6.6 6.0
HBD 2.6 1.3

Conclusion

In summary, we have implemented a reagent- and product-based sparse matrix design strategy that is both interactive and practical, involving full participation of the chemists. The key features of the compound selection are desirable physicochemical properties, diversity and built-in structural analogs and synthetic efficiency. We expect our design-synthesis-screening cycle to inform future library design and suggest refinements to our approach. As the product filters can be adjusted at the outset of the design, the property profile of the library can be tailored to meet the needs of the therapeutic area of interest (e.g., CNS, anti-bacterial).27

Supplementary Material

1_si_001

Figure 5.

Figure 5

Workflow for in silico compound selection

Acknowledgments

The authors would like to acknowledge the members of the Chemical Biology Platform who influenced the overall design strategy described here, including Dr. Michael Foley, Dr. Benito Munoz, Dr. Lawrence MacPherson and Dr. Jeremy Duvall. This work was funded in part by the NIGMS-sponsored Center of Excellence in Chemical Methodology and Library Development (Broad Institute CMLD; P50 GM069721), as well as the NIH Genomics Based Drug Discovery U54 grants Discovery Pipeline RL1CA133834 (administratively linked to NIH grants RL1HG004671, RL1GM084437, and UL1RR024924).

Footnotes

Supporting Information. Methods and software tools used for data processing are provided as well as master reagents lists and SMIRKS used for enumeration.

References

  • 1.Shelat AA, Guy K. The Interdependence between Screening Methods and Screening Libraries. Curr. Opin. Chem. Biol. 2007;11:244–251. doi: 10.1016/j.cbpa.2007.05.003. [DOI] [PubMed] [Google Scholar]
  • 2.Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery. Adv. Drug Deliv. Rev. 2001;46:3–26. doi: 10.1016/s0169-409x(00)00129-0. [DOI] [PubMed] [Google Scholar]
  • 3.(a) Cooper TWJ, Campbell IB, Macdonald SJF. Factors Determining the Selection of Organic Reactions by Medicinal Chemists and the Use of These Reactions in Arrays (Small Focused Libraries) Angew. Chem. Int. Ed. 2010;49:8082–8091. doi: 10.1002/anie.201002238. [DOI] [PubMed] [Google Scholar]; (b) Hajduk PJ, Galloway WRJD, Spring DR. Drug Discovery: A Question of Library Design. Nature. 2011;470:42–43. doi: 10.1038/470042a. [DOI] [PubMed] [Google Scholar]
  • 4.(a) Schreiber SL. Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery. Science. 2000;287(5460):1964–1969. doi: 10.1126/science.287.5460.1964. [DOI] [PubMed] [Google Scholar]; (b) Burke MD, Schreiber SL. A Planning Strategy for Diversity-Oriented Synthesis. Angew. Chem., Int. Ed. 2004;43:46–58. doi: 10.1002/anie.200300626. [DOI] [PubMed] [Google Scholar]; (c) Neilson TE, Schreiber SL. Towards the Optimal Screening Collection: A Synthesis Strategy. Angew. Chem., Int. Ed. 2007;74:48–56. doi: 10.1002/anie.200703073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.(a) Hobbs DW, Guo T. Library Design Concepts and Implementation Strategies. In: Ghose AK, Viswanadhan VN, editors. Combinatorial Library Design and Evaluation. New York: Marcel Dekker; 2001. pp. 1–49. [Google Scholar]; (b) Weber L. Current Status of Virtual Combinatorial Library Design. QSAR Comb. Sci. 2005;24:809–823. [Google Scholar]; (c) Brown RD, Hassan M, Waldman M. Tools for Designing Diverse, Druglike, Cost-Effective Combinatorial Libraries. In: Ghose AK, Viswanadhan VN, editors. Combinatorial Library Design and Evaluation. New York: Marcel Dekker; 2001. pp. 301–335. [Google Scholar]; (d) Blake JF. Integrating Cheminformatic Analysis in Combinatorial Chemistry. Curr. Opin. Chem. Biol. 2004;8:407–411. doi: 10.1016/j.cbpa.2004.04.017. [DOI] [PubMed] [Google Scholar]
  • 6.Jamois EA. Reagent-based and Product-based Computational Approaches in Library Design. Curr. Opin. Chem. Biol. 2003;7:326–330. doi: 10.1016/s1367-5931(03)00053-x. [DOI] [PubMed] [Google Scholar]
  • 7.Reagent-based design considers the properties of the reagent while product-based design considers the properties of the whole molecule.
  • 8.Marcaurelle LA, Comer E, Dandapani S, Duvall JR, Gerard B, Kesavan S, Lee MD, IV, Liu H, Lowe JT, Marie J-C, Mulrooney CA, Pandya BA, Rowley A, Ryba TD, Suh B-C, Wei J, Young DW, Akella LB, Ross NT, Zhang Y-L, Fass DM, Reis SA, Zhao W-Z, Haggarty SJ, Palmer M, Foley MA. An Aldol-Based Build/Couple/Pair Strategy for the Synthesis of Medium- and Large-Sized Rings: Discovery of Macrocyclic Histone Deacetylase Inhibitors. J. Am. Chem. Soc. 2010;132:16962–16976. doi: 10.1021/ja105119r. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.The SNAr-Pyr scaffold has been used to illustrate various methods for diversity analysis that we typically employ for scaffold selection, see: Akella LB, DeCaprio D. Cheminformatics approaches to analyze diversity in compound screening libraries. Curr. Opin. Chem. Biol. 2010;14:325–330. doi: 10.1016/j.cbpa.2010.03.017.
  • 10.Gerard B, Duvall JR, Lowe JT, Murillo T, Wei J, Akella LB, Marcaurelle LA. Synthesis of a Stereochemically Diverse Library of Medium-Sized Lactams and Sultams via SNAr Cycloetherification. ACS Comb. Sci. doi: 10.1021/co2000218. submitted. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Clark RD, Kar J, Akella L, Soltanshahi F. OptDesign: Extending Optimizable k-Dissimilarity Selection to Combinatorial Library Design. J. Chem. Inf. Comput. Sci. 2003;43:829–836. doi: 10.1021/ci025662h. [DOI] [PubMed] [Google Scholar]
  • 12.The same approach is applied to reagents, where the stereochemistry of the reagent is ignored during enumeration but applied during production.
  • 13.Methods and software tools used for data processing are provided in the Supporting Information.
  • 14.(a) Yasri A, Berthelot D, Gijsen H, Thielemans T, Marichal P, Engels M, Hoflack J. REALISIS: A Medicincal Chemistry-Oriented Reagent Selection, Library Design, and Profiling Platform. J. Chem. Inf. Comput. Sci. 2004;44:2199–2206. doi: 10.1021/ci049879i. [DOI] [PubMed] [Google Scholar]; (b) Valerie J, Gillet JV, Willett P, Bradshaw J. The Effectiveness of Reactant Pools for Generating Structurally-Diverse Combinatorial Libraries. J. Chem. Inf. Comput. Sci. 1997;37:731–740. [Google Scholar]; (c) Truchon JF, Bayly IC. GLARE: A New Approach for Filtering Large Reagent Lists in Combinatorial Library Design using Product Properties. J. Chem. Inf. Model. 2006;46:1536–1548. doi: 10.1021/ci0504871. [DOI] [PubMed] [Google Scholar]; (d) Rhodes N, Willett P, Dunbar JB, Jr, Humblet C. Bit-Strings Methods for Selective Compound Acquisition. J. Chem. Inf. Comput. Sci. 2000;40:210–214. doi: 10.1021/ci990428l. [DOI] [PubMed] [Google Scholar]
  • 15.A full list of general filters can be found in the Supporting Information.
  • 16.Jolliffe IT. Principal Component Analysis, Second Ed. New York: Springer; 2002. [Google Scholar]
  • 17.Principal component analysis is a data reduction technique where a number of correlated variables are transformed into a smaller number of uncorrelated variables. Each transformation is a principal component and related to the other components orthogonally, the first component explaining the maximum variance in the data and so on. Each descriptor was centered (mean was subtracted from each property value) and scaled (each property value was divided by the variance) prior to the analysis.
  • 18.(a) Potter T, Matter H. Random or Rational Design? Evaluation of Diverse Compound Subsets from Chemical Structure Databases. J. Med. Chem. 1998;41:478–488. doi: 10.1021/jm9700878. [DOI] [PubMed] [Google Scholar]; (b) Hassan M, Bielawski JP, Hempel JC, Waldman M. Optimization and Visualization of Molecular Diversity of Combinatorial Libraries. Mol. Diversity. 1996;2:64–74. doi: 10.1007/BF01718702. [DOI] [PubMed] [Google Scholar]
  • 19.See Supporting Information for an example.
  • 20.The price and availability data is inherently noisy due to the variability in quantity (i.e., price per gram) and annotations such as POA (price on asking), making it difficult to automate filtering by these attributes.
  • 21.Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD. Molecular Properties that Influence the Oral Bioavailability of Drug Candidates. J. Med. Chem. 2002;45:2615–2623. doi: 10.1021/jm020017n. [DOI] [PubMed] [Google Scholar]
  • 22.Mosley TR, Culberson JC, Kraker B, Feuston PB, Sheridan PB, Conway FJ, Forbes KJ, Chakravorty JS, Kearsley KS. Reagent Selector: Using Synthon Analysis to Visualize Reagent Properties and Assist in Combinatorial Library Design. J. Chem. Inf. Model. 2005;45:1439–1446. doi: 10.1021/ci050090x. [DOI] [PubMed] [Google Scholar]
  • 23.Cramer RD, Patterson DE, Clark RD, Soltanshahi F, Lawless MS. Virtual Compound Libraries: A New Approach to Decision Making in Molecular Discovery Research. J. Chem. Inf. Comput. Sci. 1998;38:1010–1023. [Google Scholar]
  • 24.The molecular similarity matrix between each molecule and all the other molecules in the dataset is computed based on extended connectivity fingerprints (ECFP_4), see: Rogers D, Hahn M. Extended-Connectivity Fingerprints. J. Chem. Inf. Model. 2010;50:742–754. doi: 10.1021/ci100050t.
  • 25.The similarity between each pair is recorded as Tanimoto coefficient (Tc), see: Flower DR. On the Properties of Bit String-Based Measures of Chemical Similarity. J. Chem. Inf. Comput. Sci. 1998;38:379–386.
  • 26.A list of final building blocks selected for library production are provided in Supporting Information.
  • 27.(a) Hitchcock SA, Pennington LD. Structure-Brain Exposure Relationships. J. Med. Chem. 2006;49:7559–7583. doi: 10.1021/jm060642i. [DOI] [PubMed] [Google Scholar]; (b) O’Shea R, Moser HE. Physicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery. J. Med. Chem. 2008;51:2871–2878. doi: 10.1021/jm700967e. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1_si_001

RESOURCES